Business Digest
US RNAi therapeutics company Alnylam Pharmaceuticals and healthcare major Sanofi have agreed to conclude the research and option phase of their collaboration.
Movers and Shakers
Adam Crystal, most recently oncology lead at the Novartis Institute for BioMedical Research, is the new CMO of C4 Therapeutics
Movers and shakers
US gene therapy company Abeona Therapeutics, headquartered in Dallas, has appointed João Siffert as CEO.
Movers and Shakers
Global biopharma giant AstraZeneca has announced organisational changes to support both R&D and commercial operations.
Movers and shakers
Irina Buhimschi, professor of paediatrics and obstetrics/gynaecology at the Ohio State University, US, has joined Chinese diagnostics company Shuwen Biotech as a scientific advisor.
Movers and Shakers
UK headquartered biopsy company, Angle has appointed Jan Groen as a non-executive director. Groen is currently president and CEO of MDxHealth, a Euronext listed molecular diagnostic company that develops tests for urological and other cancers.
Movers and Shakers
Tim Gatzenmeier from the Max-Planck-Institut für Kohlenforschung, Mulheim, Germany, has been awarded the $3,000 grand prize in Merck’s Alfred R. Bader Award
Movers and Shakers
US biopharmaceutical company Acorda Therapeutics, which focuses on neurological therapies, is losing its CTO Rick Batycky after 20 years’ service.
Movers and Shakers
US biopharma company Acceleron Pharma, based in Cambridge, MA, has appointed Robert K. Zeldin as CMO.
Movers and shakers
Biotechnology company Abcam, headquartered in Cambridge, UK, has appointed Peter Allen as non-executive chairman